. Author manuscript; available in PMC: 2020 Oct 1.

Published in final edited form as: J Subst Abuse Treat. 2019 Jul 24;105:37–43. doi: 10.1016/j.jsat.2019.07.010

Table A5.

Adverse Opioid-Related Events within 180 Days

	Adverse Events	Adverse Events
Tx Discontinuation		4.808^*** (0.393)
Dose = 4 mg or less	1.083 (0.102)	0.930 (0.0884)
Days of supply = 1, 0-7	1.420^*** (0.109)	1.301^*** (0.102)
Days of supply = 2, 8-15	1.493^*** (0.117)	1.394^*** (0.111)
Days pf supply = 3, 16-27	0.993 (0.126)	0.976 (0.127)
Controls	Yes	Yes
Observations	17,158	17,158

Notes: Data are from the 2011 to 2015 Health Care Cost Institute claims database and capture non-elderly adults initiating buprenorphine treatment. Coefficients are adjusted odds ratios based on multivariable logistic regressions. Robust standard errors are in parenthesis.

^***

p<0.01,

^**

p<0.05,

p<0.1.